| Basics |
ARK Genomic Revolution ETF
The investment seeks long-term growth of capital.
The fund is an actively-managed exchange-traded fund ("ETF") that will invest under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including healthcare, information technology, materials, energy and consumer discretionary, that are relevant to the fund's investment theme of the genomics revolution ("Genomics Revolution Companies"). It is non-diversified.
|
| IPO Date: |
October 31, 2014 |
| Sector: |
Innovation |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.58 | 1.56%
|
| Avg Daily Range (30 D): |
$0.58 | 1.99%
|
| Avg Daily Range (90 D): |
$0.53 | 1.90%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
1.34M |
| Avg Daily Volume (30 D): |
3.62M |
| Avg Daily Volume (90 D): |
3.01M |
| Trade Size |
| Avg Trade Size (Sh.): |
101 |
| Avg Trade Size (Sh.) (30 D): |
113 |
| Avg Trade Size (Sh.) (90 D): |
106 |
| Institutional Trades |
| Total Inst.Trades: |
4,460 |
| Avg Inst. Trade: |
$2.52M |
| Avg Inst. Trade (30 D): |
$2.16M |
| Avg Inst. Trade (90 D): |
$2.14M |
| Avg Inst. Trade Volume: |
.05M |
| Avg Inst. Trades (Per Day): |
3 |
| Market Closing Trades |
| Avg Closing Trade: |
$2.36M |
| Avg Closing Trade (30 D): |
$1.54M |
| Avg Closing Trade (90 D): |
$2.11M |
| Avg Closing Volume: |
51.27K |
|
|
|
|
|
